MASCoD-Multidimensional Assessment of Subjective Cognitive Decline

Area of Science:

• Neurology
• Gerontology
• Psychology

Background:

• Subjective cognitive decline (SCD) is a preclinical impairment impacting quality of life and potentially preceding dementia.
• Current screening tools primarily focus on memory complaints, neglecting other cognitive domains affected by SCD.
• SCD can increase patient frailty and caregiver burden, necessitating better assessment methods.

Purpose of the Study:

• To introduce the Multidimensional Assessment of Subjective Cognitive Decline (MASCoD) screening tool in English and Italian.
• To propose the preliminary adoption and pilot testing of the MASCoD tool.
• To address the limitations of existing instruments in comprehensively assessing SCD.

Main Methods:

• Development of the MASCoD tool based on literature review and expert clinical experience.
• Preliminary adoption and pilot testing of the MASCoD on a sample population.
• The tool is designed to be brief, easily integrated into clinical practice, and administered by various healthcare professionals.

Main Results:

• Pilot tests indicate the MASCoD tool is promising for differential diagnosis.
• The tool shows potential in predicting the risk of severe cognitive impairment.
• MASCoD facilitates the development of personalized care pathways for individuals with SCD.

Conclusions:

• The MASCoD tool offers a multidimensional approach to assessing subjective cognitive decline.
• Its preliminary adoption suggests utility in clinical settings for early detection and risk stratification.
• Further validation of MASCoD is expected to enhance the global assessment of cognitive changes in SCD.